Aveanna Healthcare Revises FY24 Revenue Forecast To Greater Than $1.97B (Est $1.975B), Updated From Prior Guidance Of $1.96M-$1.98B
Portfolio Pulse from Benzinga Newsdesk
Aveanna Healthcare has updated its FY24 revenue forecast to over $1.97B, surpassing the estimated $1.975B and previous guidance of $1.96B-$1.98B. The company also revised its Adjusted EBITDA expectation to more than $150 million, up from the prior range of $146 million to $150 million.

May 09, 2024 | 10:34 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aveanna Healthcare revises FY24 revenue forecast upwards to over $1.97B and Adjusted EBITDA to more than $150M, indicating stronger financial performance than previously anticipated.
The upward revision in both revenue forecast and Adjusted EBITDA for FY24 suggests that Aveanna Healthcare is expecting stronger financial performance than previously anticipated. This positive adjustment is likely to instill confidence among investors, potentially leading to a positive impact on the stock price in the short term. The increase in guidance above both the previous estimates and the market's expectations could be seen as a strong indicator of the company's growth trajectory and operational efficiency improvements.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100